Committed to fostering Australian research while maintaining a strong collaborative relationship with FAST United States and global patient organisations. 

We focus our efforts on determining areas of unmet Angelman Syndrome research in line with the global vision for a cure and identify opportunites to fund research to address those gaps.

See where we have invested funds in research below.

 

Enabling

  • Global Angelman Syndrome Registry
  • Generation of an Angelman Syndrome model cell line
  • Generation of mouse lines expressing human UBE3A antisense
  • Development and characterization of a pig model of AS
  • Quantifying EEG Abnormalities and identifying biomarkers in Angelman Syndrome

 

Learning


 

Treatments

  • Potential therapeutic approach for synaptic deficit in Angelman Syndrome
 

 



Enquire

Ask a question about our research or apply for research funding.>

Published Research

View Research articles on Angelman Syndrome from Pubmed.>

FAST United States

FAST is the vision of Paula Evans whose daughter Ainsley has Angelman Syndrome.  FAST launced in 2008 and they have funded an impressive amount of research in their short years.  FAST Australia Chairperson Meagan Cross sits on the board of FAST US, ensuring our organisations work collaboratively towards our goal. Read about their research and visit their website here....>

 


Copyright © Foundation for Angelman Syndrome Therapeutics • Privacy Policy | Terms of Use
F.A.S.T. Australia • PO Box 248 • Salisbury • Queensland • 4107 • Phone 1300 078 108 • FAX 07 4032 5255